CA1050427A - Preparation pharmaceutique contenant de la sapogenine, principe actif de l'hellebore - Google Patents

Preparation pharmaceutique contenant de la sapogenine, principe actif de l'hellebore

Info

Publication number
CA1050427A
CA1050427A CA224,029A CA224029A CA1050427A CA 1050427 A CA1050427 A CA 1050427A CA 224029 A CA224029 A CA 224029A CA 1050427 A CA1050427 A CA 1050427A
Authority
CA
Canada
Prior art keywords
roots
rhizomes
principal
helleborus
sapogenin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA224,029A
Other languages
English (en)
Other versions
CA224029S (en
Inventor
Otto Isaac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evonik Operations GmbH
Original Assignee
Deutsche Gold und Silber Scheideanstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2416978A external-priority patent/DE2416978A1/de
Priority claimed from DE2416979A external-priority patent/DE2416979C3/de
Application filed by Deutsche Gold und Silber Scheideanstalt filed Critical Deutsche Gold und Silber Scheideanstalt
Application granted granted Critical
Publication of CA1050427A publication Critical patent/CA1050427A/fr
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA224,029A 1974-04-08 1975-04-08 Preparation pharmaceutique contenant de la sapogenine, principe actif de l'hellebore Expired CA1050427A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2416978A DE2416978A1 (de) 1974-04-08 1974-04-08 Arzneimittel mit dem hauptsapogenin der helleborus-arten als wirkstoff
DE2416979A DE2416979C3 (de) 1974-04-08 1974-04-08 Verfahren zur Gewinnung des in den Wurzeln und Rhizomen von Helleborus-Arten enthaltenen Hauptsapogenins

Publications (1)

Publication Number Publication Date
CA1050427A true CA1050427A (fr) 1979-03-13

Family

ID=25766942

Family Applications (1)

Application Number Title Priority Date Filing Date
CA224,029A Expired CA1050427A (fr) 1974-04-08 1975-04-08 Preparation pharmaceutique contenant de la sapogenine, principe actif de l'hellebore

Country Status (1)

Country Link
CA (1) CA1050427A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121445860A (zh) * 2025-12-22 2026-02-03 北京工科生科技有限公司 一种水溶性免疫复合佐剂、疫苗及其制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121445860A (zh) * 2025-12-22 2026-02-03 北京工科生科技有限公司 一种水溶性免疫复合佐剂、疫苗及其制备方法

Similar Documents

Publication Publication Date Title
Song et al. Characterization of graphislactone A as the antioxidant and free radical-scavenging substance from the culture of Cephalosporium sp. IFB-E001, an endophytic fungus in Trachelospermum jasminoides
JP2002501030A (ja) ナマコカロテノイド脂質画分産物およびその使用方法
Phillips et al. Effects of patulin on adenosine triphosphatase activities in the mouse
US3956491A (en) Medicine containing the main sapogenin of helleborus
JOSE et al. Antimutagenic and anticarcinogenic activity of Emblica officinalis Gaertn
Brownie et al. The in vitro enzymic hydroxylation of steroid hormones. 2. Enzymic 11β-hydroxylation of progesterone by ox-adrenocortical mitochondria
JPH049331A (ja) 肝機能改善剤
KR20150134491A (ko) 해양 진균에서 분리한 페니실리놀라이드 a를 유효성분으로 함유하는 염증성 질환 예방 및 치료용 조성물
CA1050427A (fr) Preparation pharmaceutique contenant de la sapogenine, principe actif de l'hellebore
JP4497566B2 (ja) アルドース還元酵素阻害剤並びに新規サポニン及び新規サポゲノール
JP3543175B2 (ja) α−グルコシダーゼ阻害物質
Kumar et al. Antiproliferative role of Indigofera aspalathoides on 20 methylcholanthrene induced fibrosarcoma in rats
JP3128823B2 (ja) 制癌化合物およびその製造法
WO2026071862A1 (fr) Composition pour atténuer l'odeur corporelle gériatrique à l'aide d'un extrait de lysimachia davurica
US20060257540A1 (en) Plant seed extract composition and process for producing the same
JPH10287582A (ja) 樹皮抽出物からなるヒスタミン遊離抑制剤
US3947479A (en) Reduction of serum lipid levels, and agents and compositions useful therefor
Shadmi et al. The pathogenic effects on animals fed with mouldy hay or given its etheric fraction
JPH09301882A (ja) 抗糖尿病剤及びその製造法
JP4607484B2 (ja) ガン転移抑制剤
CN107840814B (zh) 单环二萜化合物cassipourol及其制备方法和在制药中的用途
JPH0455167B2 (fr)
KR101590546B1 (ko) 1-메틸-1h-벤즈이미다졸 유도체를 유효성분으로 함유하는 항산화용 조성물
JP2783848B2 (ja) 新規ホスファチジルコリンカルシウムとその製法
KR100648617B1 (ko) 누룩치로부터 분리된 부들레자사포닌 ⅳ을 함유하는 염증질환의 예방 및 치료용 조성물